Enlivex Therapeutics Ltd.

NASDAQ:ENLV

Biotechnology

Healthcare
$4.26 +2.67%

+$0.19 today

Market cap
$71.70M
Beta
1.52
P/E (TTM)
0.0
EPS (TTM)
$407.81
52W Low $6.42High $31.50

Volume 0.06M

Average 0.44M

Price history

Enlivex Therapeutics Ltd. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-70.98%

Period high

$18.15

Period low

$4.20

Latest

$4.26

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
6-KJul 20, 2026Jul 20, 2026
6-KJul 13, 2026Jul 13, 2026
6-KJul 7, 2026Jul 7, 2026
6-KJun 24, 2026Jun 24, 2026
6-KJun 22, 2026Jun 22, 2026
6-KMay 28, 2026May 28, 2026
6-KMay 27, 2026May 27, 2026
6-KMay 18, 2026May 18, 2026
6-KMay 15, 2026May 15, 2026
424B3May 1, 2026May 1, 2026
F-3Apr 21, 2026Apr 21, 2026
6-KApr 21, 2026Apr 21, 2026
6-KApr 8, 2026Apr 8, 2026
6-KMar 26, 2026Mar 26, 2026
20-FMar 25, 2026Mar 25, 2026

Competitors

Who does Enlivex Therapeutics Ltd. compete with?

Open similar companies to compare their filings and price history.

Competitors

Peer companies in the same sector

Health

Questions

Filing questions

Common questions about ENLV's filings, answered from its disclosures.

What is the latest ENLV filing?

The latest filing shown is 6-K dated Jul 20, 2026.

How many recent filings does ENLV have?

Intrinsic Alpha currently shows 20 recent filings for ENLV.